PHOX2B and neuroblastoma: In conclusions, our findings demonstrate that PHOX2A expression is finely controlled during retinoic acid differentiation and suggest that, together with PHOX2B down-regulation, they may be useful biomarkers for NB staging, prognosis and treatment decision making.